![conference banner](/images/conference-banner.jpeg)
Abstract
The mononuclear complex, [Co(TAMEN)](ClO4)2(DMSO), containing the Mannich base N,N'-tetra-(4- antipyrylmethyl)-1,2-diaminoethane (TAMEN) as ligand, was synthesized and characterised by conductometric, electronic and infrared spectroscopic properties. The single-crystal X-ray structure show the presence of two well defined units, [Co(TAMEN)]2+ and (ClO4)-. The complex cation contains cobalt(II) in the pseudo octahedral environment created by the N2O4 donor set of TAMEN. The cobalt(II) complex have been screened for its cytotoxic activity against three cultured human cell lines established from hepatoma (Hep G2), breast (MCF-7) and lung (A549) cancers as well as on nontumor bovine kidney (MDBK) cells. The cytotoxic activity of the ligand TAMEN was assessed on one tumor (Hep G2) and one non-tumor (MDBK) cell lines. The cobalt(II) compound was found to decrease in a time- and concentration- dependent manner the viability of tumor (A549, MCF-7, Hep G2) cell lines, while the ligand TAMEN expressed proliferative activity on hepatoma (HepG2) and bovine kidney (MDBK) cells, especially after prolonged incubation.
Keywords: Cobalt (II), mannich base, cell viability/proliferation
Medicinal Chemistry
Title:Crystal Structure and Cytotoxic Activity of Co(II) Complex Containing N,N’-Tetra-(4-Antipyrylmethyl)-1,2-Diaminoethane (TAMEN) as Ligand
Volume: 6 Issue: 5
Author(s): Elena Maria Mosoarca, Ingo Pantenburg, Ramona Tudose, Gerd Meyer, Radostina Alexandrova, Reni Kalfin, Wolfgang Linert and Otilia Costisor
Affiliation:
Keywords: Cobalt (II), mannich base, cell viability/proliferation
Abstract: The mononuclear complex, [Co(TAMEN)](ClO4)2(DMSO), containing the Mannich base N,N'-tetra-(4- antipyrylmethyl)-1,2-diaminoethane (TAMEN) as ligand, was synthesized and characterised by conductometric, electronic and infrared spectroscopic properties. The single-crystal X-ray structure show the presence of two well defined units, [Co(TAMEN)]2+ and (ClO4)-. The complex cation contains cobalt(II) in the pseudo octahedral environment created by the N2O4 donor set of TAMEN. The cobalt(II) complex have been screened for its cytotoxic activity against three cultured human cell lines established from hepatoma (Hep G2), breast (MCF-7) and lung (A549) cancers as well as on nontumor bovine kidney (MDBK) cells. The cytotoxic activity of the ligand TAMEN was assessed on one tumor (Hep G2) and one non-tumor (MDBK) cell lines. The cobalt(II) compound was found to decrease in a time- and concentration- dependent manner the viability of tumor (A549, MCF-7, Hep G2) cell lines, while the ligand TAMEN expressed proliferative activity on hepatoma (HepG2) and bovine kidney (MDBK) cells, especially after prolonged incubation.
Export Options
About this article
Cite this article as:
Maria Mosoarca Elena, Pantenburg Ingo, Tudose Ramona, Meyer Gerd, Alexandrova Radostina, Kalfin Reni, Linert Wolfgang and Costisor Otilia, Crystal Structure and Cytotoxic Activity of Co(II) Complex Containing N,N’-Tetra-(4-Antipyrylmethyl)-1,2-Diaminoethane (TAMEN) as Ligand, Medicinal Chemistry 2010; 6 (5) . https://dx.doi.org/10.2174/157340610793358882
DOI https://dx.doi.org/10.2174/157340610793358882 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Discovery of 4-Aryl-4H-Chromenes as Potent Apoptosis Inducers Using a Cell- and Caspase-Based Anti-Cancer Screening Apoptosis Program (ASAP): SAR Studies and the Identification of Novel Vascular Disrupting Agents
Anti-Cancer Agents in Medicinal Chemistry Sirtuins Family- Recent Development as a Drug Target for Aging, Metabolism, and Age Related Diseases
Current Drug Targets The Design and Synthesis of Novel Phenothiazine Derivatives as Potential Cytotoxic Agents
Letters in Drug Design & Discovery Steroidal Oximes: Useful Compounds with Antitumor Activities
Current Medicinal Chemistry <i>In-vitro</i> Evaluation of Triazine Scaffold for Anticancer Drug Development: A Review
Current Drug Discovery Technologies Graviola Protects Against Hepatic Toxicity Associated with DMBA induced Breast Cancer <i>via</i> Restoration of Antioxidants and Attenuation of Inflammatory Pathways
Letters in Drug Design & Discovery Src Family Nonreceptor Tyrosine Kinases as Molecular Targets for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Integrins in Pulmonary Inflammatory Diseases
Current Pharmaceutical Design Potassium Channels are a New Target Field in Anticancer Drug Design
Recent Patents on Anti-Cancer Drug Discovery Hypopituitarism in the Elderly: Multifaceted Clinical and Biochemical Presentation
Current Aging Science Lifelong Endocrine Fluctuations and Related Cognitive Disorders
Current Pharmaceutical Design Apigenin, A Plant Flavone Playing Noble Roles in Cancer Prevention Via Modulation of Key Cell Signaling Networks
Recent Patents on Anti-Cancer Drug Discovery Relevance of Machine Learning to Predict the Inhibitory Activity of Small Thiazole Chemicals on Estrogen Receptor
Current Computer-Aided Drug Design Synthesis of Some 1-(Flavon-7-yl)-4,5-dihydro-1,2,4-triazin-6(1H)-ones and Related Congeners
Letters in Organic Chemistry The proNGF-p75NTR-Sortilin Signalling Complex as New Target for the Therapeutic Treatment of Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Targeting Myc in Pediatric Malignancies of the Central and Peripheral Nervous System
Current Cancer Drug Targets TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential
Current Pharmaceutical Design Analysis of Anticancer Drugs and their Metabolites by Mass Spectrometry
Current Drug Metabolism Identifying Biomarkers of Lung Cancer in the Post-Genomic Era
Current Pharmacogenomics